Omega-3 polyunsaturated fatty acids intake to regulate helicobacter pylori -associated gastric diseases as nonantimicrobial dietary approach

BioMed Research International

Volumn 2015, Issue , 2015, Pages

  Park, Jong Min ^a   Jeong, Migyeong ^a   Kim, Eun Hee ^a   Han, Young Min ^a   Kwon, Sung Hun ^a   Hahm, Ki Baik ^a  

^a CHA Cancer Prevention Research Center CHA Cancer Institute CHA Bio Complex ^*  (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

NATURAL PRODUCT; OMEGA 3 FATTY ACID; PLANT MEDICINAL PRODUCT; PROBIOTIC AGENT; DOCOSAHEXAENOIC ACID; ICOSAPENTAENOIC ACID;

ANGIOGENESIS; ANTIBACTERIAL ACTIVITY; ANTIOXIDANT ACTIVITY; ATROPHIC GASTRITIS; CANCER PREVENTION; CANCER PROGNOSIS; CANCER SURVIVAL; CELL PROLIFERATION; DIETARY INTAKE; DRUG EFFICACY; DRUG MECHANISM; ERADICATION THERAPY; EVIDENCE BASED PRACTICE; FAT INTAKE; GINSENG; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; INFLAMMATION; INTESTINE FLORA; METASTASIS POTENTIAL; NONHUMAN; OXIDATIVE STRESS; RANDOMIZED CONTROLLED TRIAL (TOPIC); REGULATORY MECHANISM; REVIEW; STOMACH CANCER; WALNUT; DIET THERAPY; DRUG EFFECTS; METABOLISM; PATHOGENICITY; PATHOLOGY;

HELICOBACTER PYLORI; JUGLANS; PANAX GINSENG;

DOCOSAHEXAENOIC ACIDS; EICOSAPENTAENOIC ACID; FATTY ACIDS, OMEGA-3; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; INFLAMMATION; PROBIOTICS;

EID: 84939497914     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2015/712363     Document Type: Review

References (106)

1. L. E. Wroblewski, R. M. Peek Jr. , and K. T. Wilson, "Helicobacter pylori and gastric cancer: factors that modulate disease risk," Clinical Microbiology Reviews, vol. 23, no. 4, pp. 713-739, 2010.
2. S.-H. Park, N. Kangwan, J.-M. Park, E.-H. Kim, and K. B. Hahm, "Non-microbial approach for Helicobacter pylori as faster track to prevent gastric cancer than simple eradication," World Journal of Gastroenterology, vol. 19, no. 47, pp. 8986-8995, 2013.
3. V. Conteduca, D. Sansonno, G. Lauletta, S. Russi, G. Ingravallo, and F. Dammacco, "H. pylori infection and gastric cancer: state of the art (Review)," International Journal of Oncology, vol. 42, no. 1, pp. 5-18, 2013.
4. B. Burlingame, C. Nishida, R. Uauy, and R. Weisell, "Fats and fatty acids in human nutrition: introduction," Annals of Nutrition and Metabolism, vol. 55, no. 1-3, pp. 5-7, 2009.
5. W. Xin, W. Wei, and X. Li, "Effects of fish oil supplementation on cardiac function in chronic heart failure: a meta-analysis of randomised controlled trials," Heart, vol. 98, no. 22, pp. 1620-1625, 2012.
6. S. Kar and R. Webel, "Fish oil supplementation and coronary artery disease: does it help?"Missouri Medicine, vol. 109, no. 2, pp. 142-145, 2012.
7. E. A. Miles and P. C. Calder, "Influence ofmarine n-3 polyunsaturated fatty acids on immune function and a systematic review of their effects on clinical outcomes in rheumatoid arthritis," British Journal of Nutrition, vol. 107, supplement 2, pp. S171-S184, 2012.
8. I. Rudkowska, "Fish oils for cardiovascular disease: impact on diabetes," Maturitas, vol. 67, no. 1, pp. 25-28, 2010.
9. R. S. Chapkin, W. Kim, J. R. Lupton, and D. N. McMurray, "Dietary docosahexaenoic and eicosapentaenoic acid: emerging mediators of inflammation," Prostaglandins Leukotrienes and Essential Fatty Acids, vol. 81, no. 2-3, pp. 187-191, 2009.
10. P. C. Calder, "Immunomodulation by omega-3 fatty acids," Prostaglandins Leukotrienes and Essential Fatty Acids, vol. 77, no. 5-6, pp. 327-335, 2007.
11. V. C. Vaughan, M.-R.Hassing, and P. A. Lewandowski, "Marine polyunsaturated fatty acids and cancer therapy, " British Journal of Cancer, vol. 108, no. 3, pp. 486492, 2013.
12. A. J. Cockbain, G. J. Toogood, and M. A. Hull, "Omega-3 polyunsaturated fatty acids for the treatment and prevention of colorectal cancer," Gut, vol. 61, no. 1, pp. 135-149, 2012.
13. J. A. Stephenson, O. Al-Taan, A. Arshad, B. Morgan, M. S. Metcalfe, and A. R. Dennison, "The multifaceted effects of omega-3 polyunsaturated Fatty acids on the hallmarks of cancer," Journal of Lipids, vol. 2013, Article ID 261247, 13 pages, 2013.
14. V. C. Pratt, S. Watanabe, E. Bruera et al., "Plasma and neutrophil fatty acid composition in advanced cancer patients and response to fish oil supplementation, " British Journal of Cancer, vol. 87, no. 12, pp. 13701378, 2002.
15. S. McClinton, L. E. F. Moffat, D. F. Horrobin, and M. S. Manku, "Abnormalities of essential fatty acid distribution in the plasma phospholipids of patients with bladder cancer," British Journal of Cancer, vol. 63, no. 2, pp. 314-316, 1991.
16. S. D. Z. V. Leeuwen, M. S. van der Heijden, T. Rietveld et al. , "Fatty acid composition of plasma lipids in patients with pancreatic, lung and oesophageal cancer in comparison with healthy subjects," Clinical Nutrition, vol. 21, no. 3, pp. 225-230, 2002.
17. M. R. Moore and R. A. King, "Effects of omega-3 fatty acids on progestin stimulation of invasive properties in breast cancer," Hormones and Cancer, vol. 3, no. 5-6, pp. 205-217, 2012.
18. N. Sawada, M. Inoue, M. Iwasaki et al. , "Consumption of n-3 fatty acids and fish reduces risk of hepatocellular carcinoma," Gastroenterology, vol. 142, no. 7, pp. 1468-1475, 2012.
19. Z. Gu, J. Suburu, H. Chen, and Y. Q. Chen, "Mechanisms of omega-3 polyunsaturated fatty acids in prostate cancer prevention," BioMed Research International, vol. 2013, Article ID 824563, 10 pages, 2013.
20. E. Fasano, S. Serini, E. Piccioni, I. Innocenti, and G. Calviello, "Chemoprevention of lung pathologies by dietary n-3 polyunsaturated fatty acids," Current Medicinal Chemistry, vol. 17, no. 29, pp. 3358-3376, 2010.
21. M. Spite, "Deciphering the role of n-3 polyunsaturated fatty acid-derived lipid mediators in health and disease," Proceedings of the Nutrition Society, vol. 72, no. 4, pp. 441-450, 2013.
22. J. W. Fetterman Jr. and M. M. Zdanowicz, "Therapeutic potential of n-3 polyunsaturated fatty acids in disease," American Journal of Health-System Pharmacy, vol. 66, no. 13, pp. 1169-1179, 2009.
23. P. C. Calder, "n-3 polyunsaturated fatty acids, inflammation, and inflammatory diseases," The American Journal of Clinical Nutrition, vol. 83, no. 6, supplement, pp. 1505S-1519S, 2006.
24. P. C. Calder, "Dietarymodification of inflammation with lipids," Proceedings of the Nutrition Society, vol. 61, no. 3, pp. 345-358, 2002.
25. A. P. Simopoulos, "Omega-3 fatty acids in inflammation and autoimmune diseases," Journal of the American College of Nutrition, vol. 21, no. 6, pp. 495-505, 2002.
26. C. M. Yates, P. C. Calder, and G. Ed Rainger, "Pharmacology and therapeutics of omega-3 polyunsaturated fatty acids in chronic inflammatory disease," Pharmacology andTherapeutics, vol. 141, no. 3, pp. 272-282, 2014.
27. J. M. Kremer, "n-3 fatty acid supplements in rheumatoid arthritis,"The American Journal of Clinical Nutrition, vol. 71, no. 1, supplement, pp. 349S-351S, 2000.
28. R. J. Goldberg and J. Katz, "A meta-analysis of the analgesic effects of omega-3 polyunsaturated fatty acid supplementation for inflammatory joint pain," Pain, vol. 129, no. 1-2, pp. 210-223, 2007.
29. N. Kangwan, J. M. Park, and K. B. Hahm, "Development of GIsafeNSAID; progression fromthe bark ofwillow tree tomodern pharmacology," Current Opinion in Pharmacology, vol. 19, pp. 17-23, 2014.
30. A. B. Hawthorne, T. K. Daneshmend, C. J. Hawkeya et al. , "Treatment of ulcerative colitis with fish oil supplementation: a prospective 12 month randomised controlled trial," Gut, vol. 33, no. 7, pp. 922-928, 1992.
31. T. Shimizu, T. Fujii, R. Suzuki et al. , "Effects of highly purified eicosapentaenoic acid on erythrocyte fatty acid composition and leukocyte and colonic mucosa leukotriene B4 production in children with ulcerative colitis," Journal of PediatricGastroenterology and Nutrition, vol. 37, no. 5, pp. 581-585, 2003.
32. B. G. Feagan, W. J. Sandborn, U. Mittmann et al. , "Omega-3 free fatty acids for the maintenance of remission in crohn disease: the EPIC randomized controlled trials," The Journal of the American Medical Association, vol. 299, no. 14, pp. 1690-1697, 2008.
33. A. Yokoyama, T. Hamazaki, A. Ohshita et al. , "Effect of aerosolized docosahexaenoic acid in a mouse model of atopic asthma," International Archives of Allergy and Immunology, vol. 123, no. 4, pp. 327-332, 2000.
34. S. Bilal, O. Haworth, L. Wu, K. H. Weylandt, B. D. Levy, and J. X. Kang, "Fat-1 transgenic mice with elevated omega-3 fatty acids are protected from allergic airway responses," Biochimica et Biophysica Acta, vol. 1812, no. 9, pp. 1164-1169, 2011.
35. M. Hirafuji, T. Machida, N. Hamaue, and M. Minami, "Cardiovascular protective effects of n-3 polyunsaturated fatty acids with special emphasis on docosahexaenoic acid," Journal of Pharmacological Sciences, vol. 92, no. 4, pp. 308-316, 2003.
36. S. Xia, Y. Lu, J. Wang et al. , "Melanoma growth is reduced in fat-transgenic mice: impact of omega-6/omega-3 essential fatty acids," Proceedings of the National Academy of Sciences of the United States of America, vol. 103, no. 33, pp. 12499-12504, 2006.
37. A. Leaf, C. M. Albert, M. Josephson et al. , "Prevention of fatal arrhythmias in high-risk subjects by fish oil n-3 fatty acid intake," Circulation, vol. 112, no. 18, pp. 2762-2768, 2005.
38. A. Gerbi, J.-M. Maixent, J.-L. Ansaldi et al. , "Fish oil supplementation prevents diabetes-induced nerve conduction velocity and neuroanatomical changes in rats," Journal of Nutrition, vol. 129, no. 1, pp. 207-213, 1999.
39. T. C. Coste, A. Gerbi, P. Vague, G. Pieroni, and D. Raccah, "Neuroprotective effect of docosahexaenoic acid-enriched phospholipids in experimental diabetic neuropathy," Diabetes, vol. 52, no. 10, pp. 2578-2585, 2003.
40. G. P. Lim, F. Calon, T. Morihara et al. , "A diet enriched with the omega-3 fatty acid docosahexaenoic acid reduces amyloid burden in an aged Alzheimer mouse model," The Journal of Neuroscience, vol. 25, no. 12, pp. 3032-3040, 2005.
41. P. C. Calder, "Marine omega-3 fatty acids and inflammatory processes: effects, mechanisms and clinical relevance," Biochimica et Biophysica Acta-Molecular and Cell Biology of Lipids, 2014.
42. D. Schottenfeld and J. Beebe-Dimmer, "Chronic inflammation: a common and important factor in the pathogenesis of neoplasia," CA:ACancer Journal for Clinicians, vol. 56, no. 2, pp. 69-83, 2006.
43. M. Correia, V. Michel, A. A. Matos et al. , "Docosahexaenoic acid inhibits Helicobacter pylori growth in vitro and mice gastric mucosa colonization," PLoS ONE, vol. 7, no. 4, Article ID e35072, 2012.
44. L. Thompson, A. Cockayne, and R. C. Spiller, "Inhibitory effect of polyunsaturated fatty acids on the growth of Helicobacter pylori: a possible explanation of the effect of diet on peptic ulceration," Gut, vol. 35, no. 11, pp. 1557-1561, 1994.
45. A. Mohammed, N. B. Janakiram, M. Brewer et al. , "Endogenous n-3 polyunsaturated fatty acids delay progression of pancreatic ductal adenocarcinoma in Fat-1-p48cre/+-LSL-KrasG12D/+ mice," Neoplasia, vol. 14, no. 12, pp. 1249-1259, 2012.
46. K. Kuriki, K. Wakai, K. Matsuo et al. , "Gastric cancer risk and erythrocyte composition of docosahexaenoic acid with antiinflammatory effects," Cancer Epidemiology Biomarkers and Prevention, vol. 16, no. 11, pp. 2406-2415, 2007.
47. C. Otto, U. Kaemmerer, B. Illert et al. , "Growth of human gastric cancer cells in nude mice is delayed by a ketogenic diet supplemented with omega-3 fatty acids andmedium-chain triglycerides," BMC Cancer, vol. 8, article 122, 2008.
48. M.-H. Wu, Y.-T. Tsai, K.-T. Hua, K.-C. Chang, M.-L. Kuo, and M.-T. Lin, "Eicosapentaenoic acid and docosahexaenoic acid inhibit macrophage-induced gastric cancer cell migration by attenuating the expression of matrix metalloproteinase 10," Journal ofNutritional Biochemistry, vol. 23, no. 11, pp. 1434-1439, 2012.
49. Q. Wu, J. C. Yu, Y. Q. Liu, W. M. Kang, and W. D. Guo, "Effect of combination of docosahexaenoic acid and fluorouracil on human gastric carcinoma cell strain MGC803," Zhongguo Yi Xue Ke Xue Yuan Xue Bao, vol. 32, no. 1, pp. 65-70, 2010.
50. J. H. Yu, S.-G. Kang, U.-Y. Jung, C.-H. Jun, and H. Kim, "Effects of omega-3 fatty acids on apoptosis of human gastric epithelial cells exposed to silica-immobilized glucose oxidase," Annals of the New York Academy of Sciences, vol. 1171, pp. 359-364, 2009.
51. S. E. Lee, J. W. Lim, and H. Kim, "Activator protein-1 mediates docosahexaenoic acid-induced apoptosis of human gastric cancer cells," Annals of the New York Academy of Sciences, vol. 1171, pp. 163-169, 2009.
52. C. H. MacLean, S. J. Newberry, W. A. Mojica et al. , "Effects of omega-3 fatty acids on cancer risk: a systematic review," The Journal of the American Medical Association, vol. 295, no. 4, pp. 403-415, 2006.
53. A. Nakaya, H. Wakabayashi, L. Imamura et al. , "Helicobacter pylori alters n-6 fatty acid metabolism and prostaglandin E2 synthesis in rat gastric mucosal cells," Journal of Gastroenterology and Hepatology, vol. 16, no. 11, pp. 1197-1205, 2001.
54. D. Hollander and A. Tarnawski, "Is there a role for dietary essential fatty acids in gastroduodenal mucosal protection?"Journal of Clinical Gastroenterology, vol. 13, no. 1, pp. S72-S74, 1991.
55. V. Manjari and U. N. Das, "Effect of polyunsaturated fatty acids on dexamethasone-induced gastric mucosal damage," Prostaglandins Leukotrienes and Essential Fatty Acids, vol. 62, no. 2, pp. 85-96, 2000.
56. A. E. Duggan, J. C. Atherton, A. Cockayne et al. , "Clarification of the link between polyunsaturated fatty acids and Helicobacter pylori-associated duodenal ulcer disease: a dietary intervention study," British Journal of Nutrition, vol. 78, no. 4, pp. 515-522, 1997.
57. S. E. Lee, J. W. Lim, J. M. Kim, and H. Kim, "Anti-inflammatory mechanism of polyunsaturated fatty acids in Helicobacter pylori-infected gastric epithelial cells," Mediators of Inflammation, vol. 2014, Article ID 128919, 12 pages, 2014.
58. M. Correia, V. Michel, H. Os̈orio et al. , "Crosstalk between Helicobacter pylori and gastric epithelial cells is impaired bydocosahexaenoic acid," PLoS ONE, vol. 8, no. 4, Article ID e60657, 2013.
59. H. L. Woodworth, S. J. McCaskey, D. M. Duriancik et al. , "Dietary fish oil alters T lymphocyte cell populations and exacerbates disease in a mouse model of inflammatory colitis," Cancer Research, vol. 70, no. 20, pp. 7960-7969, 2010.
60. L. M. Butler and M. C. Yu, "Fish oil exacerbates colitis in SMAD3 mice," Cancer Research, vol. 71, no. 1, pp. 287-288, 2011.
61. E. A. Gurzell, H. Teague, M. Harris, J. Clinthorne, S. R. Shaikh, and J. I. Fenton, "DHA-enriched fish oil targets B cell lipid microdomains and enhances ex vivo and in vivo B cell function," Journal of Leukocyte Biology, vol. 93, no. 4, pp. 463-470, 2013.
62. S. R. Shaikh, B. D. Rockett, M. Salameh, and K. Carraway, "Docosahexaenoic acid modifies the clustering and size of lipid rafts and the lateral organization and surface expression of MHC class I of EL4 cells," The Journal of Nutrition, vol. 139, no. 9, pp. 1632-1639, 2009.
63. B. D. Rockett, H. Teague, M. Harris et al. , "Fish oil increases raft size andmembrane order of B cells accompanied by differential effects on function," Journal of Lipid Research, vol. 53, no. 4, pp. 674-685, 2012.
64. R. Meier, A. Wettstein, J. Drewe, and H. R. Geiser, "Fish oil (Eicosapen) is less effective thanmetronidazole, in combination with pantoprazole and clarithromycin, for Helicobacter pylori eradication," Alimentary Pharmacology and Therapeutics, vol. 15, no. 6, pp. 851-855, 2001.
65. H. A. Marsman, W. de Graaf, M. Heger et al. , "Hepatic regeneration and functional recovery following partial liver resection in an experimental model of hepatic steatosis treated with omega-3 fatty acids," British Journal of Surgery, vol. 100, no. 5, pp. 674-683, 2013.
66. H. F. Turk, J. M. Monk, Y.-Y. Fan, E. S. Callaway, B. Weeks, and R. S. Chapkin, "Inhibitory effects of omega-3 fatty acids on injury-induced epidermal growth factor receptor transactivation contribute to delayed wound healing," American Journal of Physiology-Cell Physiology, vol. 304, no. 9, pp. C905-C917, 2013.
67. L. Gao, D. Faibish, G. Fredman et al. , "Resolvin E1 and chemokine-like receptor 1 mediate bone preservation," Journal of Immunology, vol. 190, no. 2, pp. 689-694, 2013.
68. J. F. Tarlton, L. J. Wilkins, M. J. Toscano, N. C. Avery, and L. Knott, "Reduced bone breakage and increased bone strength in free range laying hens fed omega-3 polyunsaturated fatty acid supplemented diets," Bone, vol. 52, no. 2, pp. 578-586, 2013.
69. S. Bohr, S. J. Patel, D. Sarin, D. Irimia, M. L. Yarmush, and F. Berthiaume, "Resolvin D2 prevents secondary thrombosis and necrosis in a mouse burn wound model," Wound Repair and Regeneration, vol. 21, no. 1, pp. 35-43, 2013.
70. W. Zhuang, G. Wang, L. Li, G. Lin, and Z. Deng, "Omega-3 polyunsaturated fatty acids reduce vascular endothelial growth factor production and suppress endothelial wound repair," Journal of Cardiovascular Translational Research, vol. 6, no. 2, pp. 287-293, 2013.
71. A. D. Widgerow, "Cellular resolution of inflammation-catabasis," Wound Repair and Regeneration, vol. 20, no. 1, pp. 2-7, 2012.
72. S. J. Gladman, W. Huang, S.-N. Lim et al. , "Improved outcome after peripheral nerve injury in mice with increased levels of endogenous omega-3 polyunsaturated fatty acids," The Journal of Neuroscience, vol. 32, no. 2, pp. 563-571, 2012.
73. B. Ekçi, I. Karabicak, P. Atukeren, E. Altinli, K. Tomaoglu, and I. Tasci, "The effect of omega-3 fatty acid and ascorbic acid on healing of ischemic colon anastomoses," Annali Italiani di Chirurgia, vol. 82, no. 6, pp. 475-479, 2011.
74. Y.-D. Qiu, S. Wang, Y. Yang, and X.-P. Yan, "Omega-3 polyunsaturated fatty acids promote liver regeneration after 90% hepatectomy in rats,"World Journal of Gastroenterology, vol. 18, no. 25, pp. 3288-3295, 2012.
75. J. W. Alexander, H. Saito, O. Trocki, and C. K. Ogle, "The importance of lipid type in the diet after burn injury," Annals of Surgery, vol. 204, no. 1, pp. 1-8, 1986.
76. M. S. Cortina, J. He, N. Li, N. G. Bazan, and H. E. P. Bazan, "Neuroprotectin D1 synthesis and corneal nerve regeneration after experimental surgery and treatment with PEDF plus DHA," Investigative Ophthalmology and Visual Science, vol. 51, no. 2, pp. 804-810, 2010.
77. O. Chow and A. Barbul, "Immunonutrition: role in wound healing and tissue regeneration," Advances in Wound Care, vol. 3, no. 1, pp. 46-53, 2014.
78. P. Martin and S. J. Leibovich, "Inflammatory cells duringwound repair: the good, the bad and the ugly," Trends in Cell Biology, vol. 15, no. 11, pp. 599-607, 2005.
79. L. Lluís, N. Taltavull, M. Muñoz-Cortés et al. , "Protective effect of the omega-3 polyunsaturated fatty acids: Eicosapentaenoic acid/Docosahexaenoic acid 1:1 ratio on cardiovascular disease risk markers in rats," Lipids in Health and Disease, vol. 12, no. 1, article 140, 2013.
80. N. Avramovic, V. Dragutinovic, D. Krstic et al. , "The effecects of omega 3 fatty acid supplementation on brain tissue oxidative status in aged Wistar rats," Hippokratia, vol. 16, no. 3, pp. 241-245, 2012.
81. R. Crupi, A. Marino, and S. Cuzzocrea, "n-3 fatty acids: role in neurogenesis and neuroplasticity," Current Medicinal Chemistry, vol. 20, no. 24, pp. 2953-2963, 2013.
82. S. R. Shaikh, "Diet-induced docosahexaenoic acid non-raft domains and lymphocyte function," Prostaglandins Leukotrienes and Essential Fatty Acids, vol. 82, no. 4-6, pp. 159-164, 2010.
83. G. Calviello, S. Serini, and E. Piccioni, "n-3 polyunsaturated fatty acids and the prevention of colorectal cancer: molecular mechanisms involved," CurrentMedicinal Chemistry, vol. 14, no. 29, pp. 3059-3069, 2007.
84. B. D. Rockett, A. Franklin, M. Harris, H. Teague, A. Rockett, and S. R. Shaikh, "Membrane raft organization is more sensitive to disruption by (n-3) PUFA than nonraft organization in EL4 and B cells," Journal of Nutrition, vol. 141, no. 6, pp. 1041-1048, 2011.
85. J. Kim, Y.-N. Cha, and Y.-J. Surh, "A protective role of nuclear factor-erythroid 2-related factor-2 (Nrf2) in inflammatory disorders," Mutation Research, vol. 690, no. 1-2, pp. 12-23, 2010.
86. L. Gao, J. Wang, K. R. Sekhar et al. , "Novel n - 3 fatty acid oxidation products activate Nrf2 by destabilizing the association betweenKeap1 andCullin3,"The Journal of Biological Chemistry, vol. 282, no. 4, pp. 2529-2537, 2007.
87. Y.-C. Yang, C.-K. Lii, Y.-L. Wei et al. , "Docosahexaenoic acid inhibition of inflammation is partially via cross-talk between Nrf2/heme oxygenase 1 andIKK/NF-kappaBpathways," Journal of Nutritional Biochemistry, vol. 24, no. 1, pp. 204-212, 2013.
88. H. Wang, T. O. Khor, C. L. L. Saw et al. , "Role of Nrf2 in suppressing LPS-induced inflammation in mouse peritoneal macrophages by polyunsaturated fatty acids docosahexaenoic acid and eicosapentaenoic acid," Molecular Pharmaceutics, vol. 7, no. 6, pp. 2185-2193, 2010.
89. S. Ye, L. Tan, J. Ma, Q. Shi, and J. Li, "Polyunsaturated docosahexaenoic acid suppresses oxidative stress induced endothelial cell calcium influx by altering lipid composition in membrane caveolar rafts," Prostaglandins Leukotrienes and Essential Fatty Acids, vol. 83, no. 1, pp. 37-43, 2010.
90. N. Uemura, S. Okamoto, S. Yamamoto et al. , "Helicobacter pylori infection and the development of gastric cancer," New England Journal of Medicine, vol. 345, no. 11, pp. 784-789, 2001.
91. T. Watanabe, M. Tada, H. Nagi, S. Sasaki, and M. Nakao, "Helicobacter pylori infection induces gastric cancer in Mongolian gerbils," Gastroenterology, vol. 115, no. 3, pp. 642-648, 1998.
92. E. J. Kuipers, J. C. Thijs, and H. P. M. Festen, "The prevalence of Helicobacter pylori in peptic ulcer disease," Alimentary Pharmacology andTherapeutics, vol. 9, supplement 2, pp. 59-69, 1995.
93. K. B. Hahm, K. J. Lee, J. H. Kim, S. W. Cho, and M. H. Chung, "Helicobacter pylori infection, oxidative DNA damage, gastric carcinogenesis, and reversibility by rebamipide," Digestive Diseases and Sciences, vol. 43, no. 9, supplement, pp. 72S-77S, 1998.
94. E. E. Mannick, L. E. Bravo, G. Zarama et al. , "Inducible nitric oxide synthase, nitrotyrosine, and apoptosis in Helicobacter pylori gastritis: effect of antibiotics and antioxidants," Cancer Research, vol. 56, no. 14, pp. 3238-3243, 1996.
95. E. J. ORourke, C. Chevalier, A. V. Pinto et al. , "Pathogen DNA as target for host-generated oxidative stress: role for repair of bacterial DNA damage in Helicobacter pylori colonization," Proceedings of the National Academy of Sciences of the United States of America, vol. 100, no. 5, pp. 2789-2794, 2003.
96. D. Bagchi, T. R. McGinn, X. Ye et al. , "Helicobacter pyloriinduced oxidative stress and DNA damage in a primary culture of human gastricmucosal cells," Digestive Diseases and Sciences, vol. 47, no. 6, pp. 1405-1412, 2002.
97. S. K. Lam and N. J. Talley, "Report of the 1997 Asia Pacific Consensus Conference on the management of Helicobacter pylori infection," Journal of Gastroenterology and Hepatology, vol. 13, no. 1, pp. 1-12, 1998.
98. "Current European concepts in themanagement of Helicobacter pylori infection. The Maastricht consensus report. European Helicobacter pylori study group," Gut, vol. 41, no. 1, pp. 8-13, 1997.
99. F. Mégraud and H. Lamouliatte, "Review article: the treatment of refractory Helicobacter pylori infection," Alimentary Pharmacology and Therapeutics, vol. 17, no. 11, pp. 1333-1343, 2003.
100. S. Szabo, J. S. Trier, A. Brown, J. Schnoor, H. D. Homan, and J. C. Bradford, "A quantitative method for assessing the extent of experimental gastric erosions and ulcers," Journal of Pharmacological Methods, vol. 13, no. 1, pp. 59-66, 1985.
101. A. Asadipour, N. Edraki, M. Nakhjiri et al. , "Anti-Helicobacter pylori activity and structure-activity relationship study of 2-alkylthio-5-(nitroaryl)-1, 3, 4-thiadiazole derivatives," Iranian Journal of Pharmaceutical Research, vol. 12, no. 3, pp. 281-287, 2013.
102. Y. Minami, H. Miyata, Y. Doki et al. , "omega-3 Fatty acidcontaining diet (Racol) reduces toxicity of chemoradiation therapy for patients with esophageal cancer," Gan To Kagaku Ryoho, vol. 35, no. 3, pp. 437-440, 2008.
103. P. M. Kris-Etherton, "Walnuts decrease risk of cardiovascular disease: a summary of efficacy and biologic mechanisms," Journal of Nutrition, vol. 144, no. 4, supplement, pp. 547S-554S, 2014.
104. W. E. Hardman, "Diet components can suppress inflammation and reduce cancer risk," Nutrition Research and Practice, vol. 8, no. 3, pp. 233-240, 2014.
105. W. E. Hardman, "Walnuts have potential for cancer prevention and treatment in mice," Journal of Nutrition, vol. 144, no. 4, supplement, pp. 555S-560S, 2014.
106. M. Sezikli, Z. A. Çetinkaya, F. Güzelbulut et al. , "Effects of alpha tocopherol and ascorbic acid on Helicobacter pylori colonization and the severity of gastric inflammation," Helicobacter, vol. 17, no. 2, pp. 127-132, 2012.